Nab-paclitaxel Dose Schedual for HER-2 Negative Advanced Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: nab-paclitaxel regimen1|DRUG: nab-paclitaxel regimen2
Sponsor: Peking University Cancer Hospital & Institute